These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19462222)

  • 21. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
    Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
    Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
    Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
    J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale.
    DeMarco TA; Peshkin BN; Mars BD; Tercyak KP
    J Genet Couns; 2004 Aug; 13(4):293-304. PubMed ID: 19736695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
    Butrick M; Kelly S; Peshkin BN; Luta G; Nusbaum R; Hooker GW; Graves K; Feeley L; Isaacs C; Valdimarsdottir HB; Jandorf L; DeMarco T; Wood M; McKinnon W; Garber J; McCormick SR; Schwartz MD
    Genet Med; 2015 Jun; 17(6):467-75. PubMed ID: 25232856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
    Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
    J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
    Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
    Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
    Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.
    Peshkin BN; Demarco TA; Graves KD; Brown K; Nusbaum RH; Moglia D; Forman A; Valdimarsdottir H; Schwartz MD
    Genet Test; 2008 Mar; 12(1):37-52. PubMed ID: 18373403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas.
    Chang Y; Near AM; Butler KM; Hoeffken A; Edwards SL; Stroup AM; Kohlmann W; Gammon A; Buys SS; Schwartz MD; Peshkin BN; Kinney AY; Mandelblatt JS; Chang Y; Near AM; Butler KM; Hoeffken A; Edwards SL; Stroup AM; Kohlmann W; Gammon A; Buys SS; Schwartz MD; Peshkin BN; Kinney AY; Mandelblatt JS
    J Oncol Pract; 2016 Jan; 12(1):59, e1-13. PubMed ID: 26759468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians.
    Dekanek EW; Thull DL; Massart M; Grubs RE; Rajkovic A; Mai PL
    J Genet Couns; 2020 Feb; 29(1):122-130. PubMed ID: 31729099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
    Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS
    Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.
    Graves KD; Wenzel L; Schwartz MD; Luta G; Wileyto P; Narod S; Peshkin BN; Marcus A; Cella D; Emsbo SP; Barnes D; Halbert CH
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):648-54. PubMed ID: 20200423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.
    Wakefield CE; Ratnayake P; Meiser B; Suthers G; Price MA; Duffy J; Tucker K;
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):379-85. PubMed ID: 21254855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.